XBiotech, Inc.
(NASDAQ : XBIT)

( )
XBIT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.43%74.991.0%$1746.30m
AMGNAmgen, Inc. 4.99%219.191.3%$931.17m
REGNRegeneron Pharmaceuticals, Inc. 2.16%512.332.6%$846.25m
BIIBBiogen, Inc. 5.23%316.951.5%$805.69m
VRTXVertex Pharmaceuticals, Inc. 0.80%249.661.9%$657.48m
MRNAModerna, Inc. 1.25%32.420.0%$510.65m
ILMNIllumina, Inc. 0.13%280.993.5%$491.81m
ALXNAlexion Pharmaceuticals, Inc. 4.05%98.562.0%$309.13m
AAgilent Technologies, Inc. 3.58%76.681.6%$228.40m
INCYIncyte Corp. 1.26%87.752.5%$221.05m
EXASEXACT Sciences Corp. 6.02%66.3721.0%$182.14m
SGENSeattle Genetics, Inc. -1.80%119.686.1%$161.30m
BMRNBioMarin Pharmaceutical, Inc. -0.29%79.604.3%$150.56m
NVAXNovavax, Inc. 15.30%17.18114.7%$135.65m
IMMUImmunomedics, Inc. -2.54%18.4311.9%$121.13m

Company Profile

XBiotech, Inc. is a biopharmaceutical company. The firm engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.